Literature DB >> 5067420

The bronchodilator effect of a new adrenergic aerosol--Salmefamol.

M C Kennedy, C H Dash.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 5067420     DOI： 10.1111/j.1398-9995.1972.tb01639.x

Source DB:  PubMed          Journal:  Acta Allergol        ISSN： 0001-5148


× No keyword cloud information.
  5 in total

1.  The clinical pharmacology of salmefamol.

Authors:  M E Evans; G M Shenfield; J W Paterson
Journal:  Br J Clin Pharmacol       Date:  1974-10       Impact factor: 4.335

2.  An economical method of comparing inhaled bronchodilators in reversible diffuse airways obstruction. With special reference to a beta-2 stimulant--salmefamol.

Authors:  S Lal; C H Dash; M D Gribben
Journal:  Thorax       Date:  1974-05       Impact factor: 9.139

3.  Comparison of salmefamol with salbutamol aerosols in asthamatics.

Authors:  R W Sillett; C H Dash; M W McNicol
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

4.  Comparison of salmefamol and salbutamol in patients with chronic airways obstruction.

Authors:  I A Campbell; C H Dash; G J McHardy; M V Shotter
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

5.  Salmefamol orally in asthmatics - two doses compared.

Authors:  R W Sillett; C H Dash; M W McNicol
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.